Registration successful.
Account activated – Pending validation
Your account has been activated successfully, but we still need to validate you as a UK healthcare professional. We’ll send you an email with the result. Please note this could take up to 10 days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website.
Vaccines training programme
Developed for healthcare professionals, this is a personalised e-learning portal to provide you with knowledge and training on a wide range of vaccine preventable diseases and/or malaria prophylaxis services.
Helping healthcare professionals to support patients
Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol): Now a carbon neutral triple therapy inhaler, as certified by the Carbon Trust1
A part of delivering GSK’s commitment to have a net zero impact on climate and net positive impact on nature by 2030.
Prescribing information link can be found at the bottom of this webpage.
Quick links
More resources
Get more from GSKpro
Get access to free patient resources including samples and demo devices, exclusive webinars on the topics that matter to you and updates on the latest in respiratory and more.
Reference
- Certification of carbon neutrality for Trelegy Ellipta.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/.
Adverse events should also be reported to GlaxoSmithKline UK on 0800 221 441.
November 2021 | PM-GB-NA-WCNT-210003
